Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.34 |
| ▸ | HTR1A | P08908 | 2/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5936905 | 0.98 | MEN1 (0.43) | MEN1POLBKMT2ACHRM5CHRM1 | |
| Hydrochloric Acid SCHEMBL9193442 | 0.98 | MEN1 (0.43) | MEN1POLBKMT2ACHRM5CHRM1 | |
| Phosphoric Acid SCHEMBL3447199 | 0.88 | LMNA (0.42) | MEN1POLBKMT2ACHRM5CHRM1 | |
| Phosphonic Acid SCHEMBL28825299 | 0.88 | MEN1 (0.37) | MEN1POLBKMT2ACHRM5CHRM1 | |
| SCHEMBL83823 | 0.86 | MEN1 (0.42) | MEN1POLBKMT2ASMN1; SMN2LMNA | |
| SCHEMBL327528 | 0.85 | MEN1 (0.45) | MEN1POLBKMT2ACA1CA2 | |
| SCHEMBL327742 | 0.85 | MEN1 (0.45) | MEN1POLBKMT2ACA1CA2 | |
| Phosphoric Acid SCHEMBL3446695 | 0.84 | SMN1; SMN2 (0.37) | MEN1POLBKMT2ACHRM5CHRM1 | |
| Hydrochloric Acid SCHEMBL9280456 | 0.83 | MEN1 (0.43) | MEN1POLBKMT2ACA1CA2 | |
| Bromide SCHEMBL1955038 | 0.83 | MEN1 (0.43) | MEN1POLBKMT2ACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3600380-A1 | ORAL DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | Rezolute, Inc. (US) | 2020-02-05 | — | — | EP | claimed |
| CN-110662550-A | Oral administration of physiologically active substances | 瑞泽路特有限公司 | 2020-01-07 | — | — | CN | claimed |
| US-20180271792-A1 | ORAL DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | REZOLUTE, INC. (US) | 2018-09-27 | — | — | US | claimed |
| WO-2018175250-A1 | ORAL DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | REZOLUTE, INC. (US) | 2018-09-27 | — | — | WO | claimed |
| WO-2016156559-A1 | CLAY STABILIZING COMPOSITIONS AND USE OF SAID COMPOSITIONS FOR STABILIZING WATER SENSITIVE FORMATIONS | TAMINCO BVBA (BE) | 2016-10-06 | — | — | WO | claimed |
| CN-1451004-A | 7-oxopyridopyrimidines | HOFFMANN LA ROCHE (CH) | 2003-10-22 | — | — | CN | claimed |
| EP-4536612-A1 | COMPOSITION COMPRISING A EUTECTIC MIXTURE COMPRISING AN ALKYLTHIOPHOSPHORIC TRIAMIDE UREASE INHIBITOR | SPECIALTY OPERATIONS FRANCE (FR) | 2025-04-16 | — | — | EP | disclosed |
| CN-118202067-A | Nucleic acid amplification promoter and inspection method using the same | 日油株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023237755-A1 | COMPOSITION COMPRISING A EUTECTIC MIXTURE COMPRISING AN ALKYLTHIOPHOSPHORIC TRIAMIDE UREASE INHIBITOR | SPECIALTY OPERATIONS FRANCE (FR) | 2023-12-14 | — | — | WO | disclosed |
| US-11680946-B1 | Detection of cholinesterase inhibition with microfluidic devices and systems thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2023-06-20 | — | — | US | disclosed |
| US-20210023009-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | BEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2021-01-28 | — | — | US | disclosed |
| US-10842747-B2 | Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery | Ben-Gurion University of Negev R & D (IL) | 2020-11-24 | — | — | US | disclosed |
| CN-107507999-B | Electrolyte composition and metal ion battery comprising same | 财团法人工业技术研究院 | 2019-11-08 | — | — | CN | disclosed |
| CN-103113242-A | Functional choline chloride ionic liquid and preparation method and application in electrochemical energy storage device thereof | GUANGZHOU INST ENERGY CONV CAS | 2013-05-22 | — | — | CN | disclosed |
| US-20120164072-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2012-06-28 | — | — | US | disclosed |
| EP-2427175-A2 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | Ben-gurion University Of The Negev Research And Development Authority (IL) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010128504-A2 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2010-11-11 | — | — | WO | disclosed |
| CN-101475585-A | New compound alkyl bilineurine phosphodiester (miltefosine)and preparation | YONGGANG WEI (CN) | 2009-07-08 | — | — | CN | disclosed |
| CN-100376516-C | Sulphonylation method and reagent useful for perhalogenated sulphanilide synthesis | RNODIA CHIMIE (FR) | 2008-03-26 | — | — | CN | disclosed |
| CN-1325371-A | Sulfonylation method and reagent for synthesis of perhalogenated sulphanilide | RNODIA CHIMIE (FR) | 2001-12-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164072-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | TSPO, ANXA6, ANXA11 | MEN1 334/4885POLB 3423/4885KMT2A 3066/4885 |
| US-20210023009-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | TSPO, ANXA6, ANXA11 | MEN1 334/4885POLB 3423/4885KMT2A 3066/4885 |
| US-10842747-B2 | Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery | TSPO, ANXA6, ANXA11 | MEN1 334/4885POLB 3423/4885KMT2A 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.